Hansoh Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Hansoh Pharmaceutical Group has a total shareholder equity of CN¥25.8B and total debt of CN¥4.2B, which brings its debt-to-equity ratio to 16.4%. Its total assets and total liabilities are CN¥33.0B and CN¥7.2B respectively. Hansoh Pharmaceutical Group's EBIT is CN¥2.7B making its interest coverage ratio -2.8. It has cash and short-term investments of CN¥24.9B.
Key information
16.4%
Debt to equity ratio
CN¥4.22b
Debt
Interest coverage ratio | -2.8x |
Cash | CN¥24.88b |
Equity | CN¥25.79b |
Total liabilities | CN¥7.24b |
Total assets | CN¥33.04b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: HNSP.F's short term assets (CN¥28.9B) exceed its short term liabilities (CN¥6.9B).
Long Term Liabilities: HNSP.F's short term assets (CN¥28.9B) exceed its long term liabilities (CN¥381.5M).
Debt to Equity History and Analysis
Debt Level: HNSP.F has more cash than its total debt.
Reducing Debt: HNSP.F's debt to equity ratio has increased from 0% to 16.4% over the past 5 years.
Debt Coverage: HNSP.F's debt is well covered by operating cash flow (73.8%).
Interest Coverage: HNSP.F earns more interest than it pays, so coverage of interest payments is not a concern.